We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$10.7B
AUM Growth
+$199M
Cap. Flow
-$591M
Cap. Flow %
-5.53%
Top 10 Hldgs %
13.09%
Holding
255
New
28
Increased
68
Reduced
132
Closed
22

Top Buys

Rank Stock Value
1
FROG icon
JFrog
FROG
+$56.3M
2
CSL icon
Carlisle Companies
CSL
+$54.5M
3
KMX icon
CarMax
KMX
+$50.4M
4
JKHY icon
Jack Henry & Associates
JKHY
+$45.2M
5
BAND
Bandwidth Inc
BAND
+$40.6M

Top Sells

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$79.8M
2
IRTC icon
iRhythm Holdings
IRTC
+$62.4M
3
PGR icon
Progressive
PGR
+$59.9M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$55.5M
5
PCTY icon
Paylocity
PCTY
+$54M

Sector Composition

Rank Sector Weight
1 Technology 32.85%
2 Healthcare 19.97%
3 Industrials 14.83%
4 Consumer Discretionary 10.25%
5 Financials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLDR icon
151
Builders FirstSource
BLDR
$6.48B
$28M 0.26%
+858,595
New +$23.3M
OLLI icon
152
Ollie's Bargain Outlet
OLLI
$4.37B
$27.5M 0.26%
314,595
-51,655
-14% -$5.05M
PFGC icon
153
Performance Food Group
PFGC
$14.8B
$26.2M 0.25%
758,000
-37,500
-5% -$1.21M
BFAM icon
154
Bright Horizons
BFAM
$3.25B
$25.8M 0.24%
170,000
-84,500
-33% -$10.6M
HUBS icon
155
HubSpot
HUBS
$12.5B
$25.3M 0.24%
86,600
+22,000
+34% +$5.77M
DCPH
156
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$25.2M 0.24%
490,400
-70,130
-13% -$3.44M
GNTX icon
157
Gentex
GNTX
$4.8B
$25M 0.23%
972,600
+22,600
+2% +$600K
BBIO icon
158
BridgeBio Pharma
BBIO
$14.1B
$24.3M 0.23%
646,430
-72,199
-10% -$2.27M
CRSP icon
159
CRISPR Therapeutics
CRSP
$5.12B
$24.2M 0.23%
289,700
-51,250
-15% -$4.55M
CHGG icon
160
Chegg
CHGG
$81.6M
$24.2M 0.23%
338,700
-56,300
-14% -$4.15M
AZTA icon
161
Azenta
AZTA
$1.4B
$24.2M 0.23%
522,575
-30,165
-5% -$1.46M
IPHI
162
DELISTED
INPHI CORPORATION
IPHI
$23.9M 0.22%
+213,200
New +$24.9M
NOVA
163
DELISTED
Sunnova Energy
NOVA
$23.8M 0.22%
+782,345
New +$18.5M
BR icon
164
Broadridge
BR
$19.1B
$23.7M 0.22%
179,200
-67,300
-27% -$9M
PLTR icon
165
Palantir
PLTR
$416B
$23.3M 0.22%
+2,450,000
New +$23.3M
ITT icon
166
ITT
ITT
$18.3B
$23.2M 0.22%
392,700
-27,400
-7% -$1.66M
ITCI
167
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$23.2M 0.22%
+902,500
New +$20.6M
SWAV
168
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$22.4M 0.21%
+295,560
New +$16.8M
VITL icon
169
Vital Farms
VITL
$431M
$21.5M 0.2%
+530,675
New +$20M
MNTV
170
DELISTED
Momentive Global Inc. Common Stock
MNTV
$21.2M 0.2%
960,000
+367,100
+62% +$8.53M
TTC icon
171
Toro Company
TTC
$8.78B
$21M 0.2%
+250,000
New +$18.7M
QTNT
172
DELISTED
Quotient Limited Ordinary Shares
QTNT
$20.4M 0.19%
99,288
+29,530
+42% +$7.65M
FLWS icon
173
1-800-Flowers.com
FLWS
$194M
$20.4M 0.19%
818,100
-100,900
-11% -$2.67M
LASR icon
174
nLIGHT
LASR
$2.33B
$20.2M 0.19%
861,200
-71,900
-8% -$1.65M
TLND
175
DELISTED
Talend S.A. American Depositary Shares
TLND
$19.7M 0.18%
503,370
+83,719
+20% +$3.24M
5 6
7
8 9

Similar funds

CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

TimesSquare Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, TimesSquare Capital Management held 255 positions worth $10.7B, up 1.9% from $10.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TimesSquare Capital Management withdrew a net $591M in Q3 2020, closing 22 positions and reducing 132 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $79.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in JFrog worth $64M.

  • TimesSquare Capital Management's largest Q3 2020 buy was JFrog: 755,640 shares worth $64M.
  • TimesSquare Capital Management added most to Jack Henry & Associates in Q3 2020, an estimated $45.2M increase.
  • TimesSquare Capital Management's biggest Q3 2020 reduction was iRhythm Holdings, cutting an estimated $62.4M.
  • TimesSquare Capital Management fully exited Global Blood Therapeutics, Inc. in Q3 2020, selling an estimated $79.8M.
  • TimesSquare Capital Management's ten largest holdings make up 13% of its $10.7B portfolio in Q3 2020.
  • TimesSquare Capital Management opened 28 new positions and closed 22 in Q3 2020.
  • TimesSquare Capital Management's portfolio value rose 1.9% quarter-over-quarter to $10.7B.

Based on TimesSquare Capital Management's 13F filing for Q3 2020, filed 6 Nov 2020.